TWST — Twist Bioscience Corp
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1581280 ·
Last close
$152.05
Market Cap
$10.08B
52W High
$219.71
52W Low
$23.30
ADV30
2,559,188
Next earnings
2026-11-16
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 118,376,000 | 62,454,000 | -36,280,000 | -35,051,000 | 672,437,000 | 117,436,000 | 226,698,000 |
| Mar 2026 | 110,715,000 | 57,122,000 | -38,658,000 | -44,021,000 | 676,214,000 | 122,670,000 | 221,120,000 |
| Dec 2025 | 103,698,000 | 53,972,000 | -33,100,000 | -30,507,000 | 638,085,000 | 148,591,000 | 181,990,000 |
| Sep 2025 | 99,009,000 | 50,837,000 | -29,934,000 | -27,138,000 | 641,861,000 | 183,049,000 | 168,903,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-53,072,000
Investing CF
$-45,240,000
Financing CF
$13,797,000
CapEx
$-40,151,000
Dividends Paid
—
Buybacks
$-18,000
EPS Diluted TTM
$-2.22
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,429,157,000
Inventory
$35,162,000
Receivables
$87,581,000
ST Investments
$49,403,000
EBIT TTM
$-137,972,000
Pretax Income TTM
$-135,853,000
Interest Exp TTM
$167,000
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$431,798,016
EBITDA
$-115,282,000
Free Cash Flow
$-64,822,500
Enterprise Value
$7,919,389,696
Total Cash
$166,839,008
Total Debt
$108,590,000
Shares Out
66,301,174
Trailing EPS
$-2.22
Book Value
$7.11
ROE
-29.6%
ROA
-13.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 376,572,000 | -136,259,000 | -77,670,000 | 641,861,000 | 168,903,000 | 472,958,000 | -47,628,000 |
| Sep 2024 | 312,974,000 | -175,901,000 | -208,726,000 | 614,323,000 | 141,634,000 | 472,689,000 | -64,094,000 |
| Sep 2023 | 245,109,000 | -206,903,000 | -204,618,000 | 776,403,000 | 152,971,000 | 623,432,000 | -142,474,000 |
| Sep 2022 | 203,565,000 | -249,021,000 | -217,863,000 | 961,378,000 | 171,993,000 | 789,385,000 | -124,385,000 |
TTM Snapshot
Revenues TTM
$409,479,000
NetIncome TTM
$-81,276,000
OpCashFlow TTM
—
Assets (Latest)
$676,214,000
Forward EPS
$-0.63
Max Pain — expiry 2026-10-16
max pain strike: $175.00 · spot: $159.78 · call oi: 9,369 · put oi: 7,954
Expected Move to 2026-10-16:
±$13.95
(8.73%) —
implied range
$145.83 –
$173.73
· ATM straddle on $160.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | $9.69B | $327.30 | — |
| IBRX | ImmunityBio, Inc. | $10.50B | $9.91 | — |
| PCVX | Vaxcyte, Inc. | $9.67B | $65.01 | — |
| RGEN | REPLIGEN CORP | $9.25B | $163.84 | — |
| QGEN | QIAGEN N.V. | $9.20B | $44.53 | — |
News headlines (Yahoo Finance, 1h cache)
Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
2026-10-06 12:16 · Yahoo
Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year
2026-10-05 06:44 · Yahoo
Twist Bioscience (TWST) Stock Fair Value Edges Higher As Analysts Split On AI Upside
2026-10-02 07:07 · Yahoo
Twist Bioscience (TWST) Stock Could Be Reasonable On Its 9x Three Year Run
2026-10-02 04:23 · Yahoo
What Needs To Be True To Buy Twist Bioscience Stock Now?
2026-09-25 22:29 · Yahoo
Twist Bioscience Stock Jumped 16% Thursday. Leerink Says Anthropic Made It Happen.
2026-09-25 04:36 · Yahoo
Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership
2026-09-22 10:08 · Yahoo
Practice Caution with This Hot Stock Up 493% in the Past Year
2026-09-21 15:50 · Yahoo
Why Twist Bioscience Stock Skyrocketed This Week
2026-09-18 23:56 · Yahoo
DNA Synthesis Market Outlook 2026-2035 - Featuring Profiles of Leading Companies Integrated DNA Technologies, GenScript Biotech, and Twist Bioscience
2026-09-18 10:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.